期刊文献+

C5L2基因新的SNP位点C698T与新疆地区维吾尔族人群2型糖尿病的相关性研究 被引量:2

Relationship between a novel polymorphism of C5L2 gene C698T and type 2 diabetes in Uygur population of Xinjiang region
原文传递
导出
摘要 目的本研究旨在探讨促酰化蛋白(acylation—stimulating protein,ASP)的功能受体C5L2基因新的SNP位点C698T多态性与糖尿病的相关性。方法采用直接测序的方法,在C5L2基因第二外显子区发现新的SNP位点C698T;采用PCR-限制性片段长度多态性方法,对252例2型糖尿病患者和747名健康对照者C5L2基因C698T进行分析。结果C5L2基因C698T杂合子基因型在2型糖尿病组和对照组的分布频率分别为0.107和0.036,差异有统计学意义(r=18.576,P〈0.01)。在调整了年龄、性别、吸烟、饮酒,高血压、甘油三酯、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇等混杂因素后,C698T杂合子SNP仍为新疆维吾尔族人群2型糖尿病的独立危险因素(P〈0.01,OR=3.373,95%C/1.736—6.553)。结论在新疆维吾尔族人群中,C5L2基因C698T基因多态性与2型糖尿病具有相关性,CT基因型可增加新疆维吾尔族人群2型糖尿病发生的风险。 Objective To investigate the relationship between a novel polymorphism of C5L2 gene and type 2 diabetes mellitus (T2DM) in Uygur population from Xinjiang region. Methods A novel single nueleotide polymorphism( SNP), 698C〉T(P233L) was found using a polymerase chain reaction direct-sequencing method. C5L2 gene 698C 〉 T variant from 252 patients with T2DM and 747 healthy control subjects was detected by polymerase chain reaction and restriction fragment length polymorphism. Result Heterozygote carriers of the 698CT genotype were more frequent among T2DM patients than that among controls (0. 107 vs O. 036, X2 = 18. 576, P〈 0. 01 ) in the Uygur population. After adjustment of confounding factors such as sex, age, smoking, alcohol consumption, and hypertension, as well as serum levels of triglyceride, total cholesterol, low-density lipoprotein- cholesterol, and high-density lipoprotein-cholesterol, the difference remained significant ( P 〈 0. 01, OR = 3. 373, 95% CI 1. 736-6. 553 ). Conclusion The CT genotype of the C5L2 gene might be a risk factor of T2DM in Uygur nationality population in Xinjiang.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第3期186-189,共4页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(81060021)
关键词 C5L2基因 促酰化蛋白 糖尿病 2型 维吾尔族 C5L2 gene Acylation-stimulating protein Diabetes mellitus, type 2 Uygur
  • 相关文献

参考文献14

  • 1Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010,362 : 1090-1101.
  • 2Stumvoll M, Goldstein B J, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet ,2005,365:1333-1346.
  • 3Maslowska M, Wang HW, Cianflone K. Novel roles for acylation stimulating protein/c3adesArg: a review of recent in vitro and in vivo evidence. Vitam Horm, 2005,70:309-332.
  • 4Maslowska M, Le gakisH, Assadi F, et al. Targeting the signaling pathway of acylation stimulating protein. J Lipid Res, 2006,47 : 643- 652.
  • 5Xie X, Ma YT, Yang YN, et al. Polymorphisms in the SAA1/2 Gene are associated with carotid intima media thickness in healthy Han Chinese subjects : the Cardiovascular Risk Survey. PLoS One, 2010,5 : e13997.
  • 6温宇,王宏伟,吴静,卢慧玲,夏治,Katherine Cianflone.促酰化蛋白受体C5L2在前脂肪细胞分化过程和脂肪酸负荷下的表达研究[J].中华医学杂志,2007,87(36):2571-2574. 被引量:5
  • 7Cianflone K, Roncari DA, Maslowska M, et al. Adipsin/acylation stimulating protein system in human adipocytes. Biochemistry, 1999, 33 : 9489 -9495.
  • 8Faraj M, Lu HL, Cianflone K. Diabete, lipids, and adipocyte secretagogues. Biochem Cell Biol, 2004,82 : 170-190.
  • 9Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest, 1999,29:679-686.
  • 10Cianflone K, Lu H, Smith J, et al. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol( Oxf), 2005,62:567-572.

二级参考文献17

  • 1温宇,王宏伟,卢慧玲,胡秀芬,施虹,杨杨,康闽,王丹丹.脂肪酸诱导的3T3-L1脂肪细胞胰岛素抵抗的研究[J].中国病理生理杂志,2007,23(3):543-547. 被引量:23
  • 2Cianflone KM, Sniderman AD, Walsh MJ, et al. Purification and characterizatiou of acylation stimulating protein. J Biol Chem, 1989,264:426-430.
  • 3Cianflone K, Maslowska M, Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine:new directions. Semin Cell Der Biol, 1999,10:31-41.
  • 4Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinenia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001,86:1930-1935.
  • 5Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adiposin and lipids in non-obese and obese populations. Eur J Clin Invest, 1999,29:679-686.
  • 6Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increased plasma levels of an Adipose-derived anti-inflammatory protein,adiponectin. J Clin Endocrinol Metab, 2001,86:3815-3819.
  • 7Cianflone K, Roncari DA, Maslowska M, et al. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry, 1994,33:9489-9495.
  • 8Cianflone K. The acylation stimulating protein pathway: clinical implications. Clin Biochem, 1997,30:301-312.
  • 9Saleh J,Summers LK,Cianflone K,et al.Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period[].Journal of Lipid Research.1998
  • 10Cianflone K.Acylation stimulating protein and the adipocyte[].The Journal of Endocrinology.1997

共引文献10

同被引文献29

  • 1张眉花,韩雅菲,吴桂莲,董景梅.妊娠期糖代谢异常发生率及高危因素的前瞻性对照分析[J].中国妇产科临床杂志,2007,8(3):181-184. 被引量:14
  • 2温宇,王宏伟,吴静,卢慧玲,夏治,Katherine Cianflone.促酰化蛋白受体C5L2在前脂肪细胞分化过程和脂肪酸负荷下的表达研究[J].中华医学杂志,2007,87(36):2571-2574. 被引量:5
  • 3Faraj M, Snidennan A, Ciarlnone K. ASP enhances in situlipoprotein lipase activity by increasing fatty acidtrapping in adipocytes [J]. Lipid Res, 2004, 45:657-666.
  • 4Kalant D, MacLaren R, Cui W, et al. C5L2 is a functional receptor for acylation -stimulating protein [J]. Biol Chem, 2005, 280 (25) : 23936-23944.
  • 5Maslowska M. Novel roles for acylation stimulating protein/ C3adesArg :a review of recent in vitro and in vivo evidence [J]. Vitam Horm, 2005,70:309-332.
  • 6Maslowska M, et al. Targeting the signaling pathway of acylation stimulating protein [J]. Lipid Res, 2006, 47 ( 3 ) :643-652.
  • 7Zheng YY, Xie X, Ma YT, et al. Relationship between type 2 diabetes mellitus and a novelpolymorphism C698T in C5L2 in the Chinese Hart population [J]. Endocrine, 2012,41 (2):296-301.
  • 8Zheng YY, Xie X, Ma YT, et al. Relationship between a novel polymorphism of the C5L2 gene and coronary artery disease [J]. PLoS One, 2011,6 (6) :e20984.
  • 9Alharbi KK, Khan IA, Syed R. Circulating C5L2 gene polymorphism is associated with type 2 diabetes mellitus in Saudi population [J]. Mol Biol Rep, 2013, 40 ( 11 ) :6323-6327.
  • 10Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes [J]. Diabet Med, 2004, 21 (2) :103-113.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部